274 related articles for article (PubMed ID: 23850319)
1. Relevance of intermediate-density lipoprotein cholesterol to Framingham risk score of coronary heart disease in middle-aged men with increased non-HDL cholesterol.
Ito K; Yoshida H; Yanai H; Kurosawa H; Sato R; Manita D; Hirowatari Y; Tada N
Int J Cardiol; 2013 Oct; 168(4):3853-8. PubMed ID: 23850319
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores.
Manita D; Yoshida H; Hirowatari Y
J Atheroscler Thromb; 2017 Sep; 24(9):928-939. PubMed ID: 28025448
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men.
Yoshida H; Ito K; Manita D; Sato R; Hiraishi C; Matsui S; Hirowatari Y
Front Cardiovasc Med; 2021; 8():756057. PubMed ID: 34881308
[No Abstract] [Full Text] [Related]
4. An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein.
Koba S; Hirano T; Sakaue T; Takeuchi H; Adachi M; Katagiri T
Coron Artery Dis; 2002 Aug; 13(5):255-62. PubMed ID: 12394649
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
[TBL] [Abstract][Full Text] [Related]
6. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
Tatami R; Mabuchi H; Ueda K; Ueda R; Haba T; Kametani T; Ito S; Koizumi J; Ohta M; Miyamoto S; Nakayama A; Kanaya H; Oiwake H; Genda A; Takeda R
Circulation; 1981 Dec; 64(6):1174-84. PubMed ID: 7296792
[TBL] [Abstract][Full Text] [Related]
7. Innovatively Established Analysis Method for Lipoprotein Profiles Based on High-Performance Anion-Exchange Liquid Chromatography.
Hirowatari Y; Yoshida H
J Atheroscler Thromb; 2019 Dec; 26(12):1027-1040. PubMed ID: 31548491
[TBL] [Abstract][Full Text] [Related]
8. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
[TBL] [Abstract][Full Text] [Related]
9. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
[TBL] [Abstract][Full Text] [Related]
10. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
11. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors.
Masuda R; Wist J; Lodge S; Kimhofer T; Hunter M; Hui J; Beilby JP; Burnett JR; Dwivedi G; Schlaich MP; Bong SH; Loo RL; Holmes E; Nicholson JK; Yeap BB
J Clin Lipidol; 2023; 17(5):677-687. PubMed ID: 37442713
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol concentrations in lipoprotein fractions separated by anion-exchange-high-performance liquid chromatography in healthy dogs and dogs with hypercholesterolemia.
Oda H; Mori A; Hirowatari Y; Takoura T; Manita D; Takahashi T; Shono S; Onozawa E; Mizutani H; Miki Y; Itabashi Y; Sako T
Res Vet Sci; 2017 Oct; 114():163-169. PubMed ID: 28419940
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
[TBL] [Abstract][Full Text] [Related]
15. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease.
Liu J; Sempos CT; Donahue RP; Dorn J; Trevisan M; Grundy SM
Am J Cardiol; 2006 Nov; 98(10):1363-8. PubMed ID: 17134630
[TBL] [Abstract][Full Text] [Related]
16. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.
Steiner G; Schwartz L; Shumak S; Poapst M
Circulation; 1987 Jan; 75(1):124-30. PubMed ID: 3791598
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary modification by calorie restriction on cholesterol levels in lipoprotein(a) and other lipoprotein classes.
Hirowatari Y; Manita D; Kamachi K; Tanaka A
Ann Clin Biochem; 2017 Sep; 54(5):567-576. PubMed ID: 27638928
[TBL] [Abstract][Full Text] [Related]
18. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
[TBL] [Abstract][Full Text] [Related]
19. Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes.
Schmidt AF; Joshi R; Gordillo-Marañón M; Drenos F; Charoen P; Giambartolomei C; Bis JC; Gaunt TR; Hughes AD; Lawlor DA; Wong A; Price JF; Chaturvedi N; Wannamethee G; Franceschini N; Kivimaki M; Hingorani AD; Finan C
Commun Med (Lond); 2023 Jan; 3(1):9. PubMed ID: 36670186
[TBL] [Abstract][Full Text] [Related]
20. Effect of ezetimibe on low- and high-density lipoprotein subclasses in sitosterolemia.
Othman RA; Myrie SB; Mymin D; Roullet JB; Steiner RD; Jones PJH
Atherosclerosis; 2017 May; 260():27-33. PubMed ID: 28340366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
